DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Buprenex (Buprenorphine Hydrochloride) - Current Clinical Trials

 
 



Buprenex Related Clinical Trials

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome [Completed]

Preference for Subutex� (Buprenorphine) Versus Suboxone� (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex� (Study P05094)(COMPLETED) [Completed]

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction [Completed]

Disposition Effects of Cyclosporin on Buprenorphine [Recruiting]

Buprenorphine Treatment for Opioid Dependence [Recruiting]

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Recruiting]

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects [Completed]

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) [Enrolling by invitation]

Buprenorphine Used With Treatment Resistant Depression in Older Adults [Not yet recruiting]

Buprenorphine Group Medical Visits in Primary Care [Not yet recruiting]

Integrating Buprenorphine Into the SFGH AIDS Program [Completed]

Buprenorphine for Treatment Resistant Depression [Completed]

Multiple Dose Study of Blockade of Opioid Effects of Injections of Buprenorphine in Participants With Opioid Disorder [Completed]

Butrans for Treatment of Restless Legs Syndrome [Withdrawn]

Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome [Recruiting]

Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients [Not yet recruiting]

Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone [Completed]

An Open Label Study To Assess The Safety And Tolerability Of BEMA� Buprenorphine NX In Opioid Dependent Subjects [Completed]

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) [Completed]

A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) [Completed]

Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines [Recruiting]

Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Completed]

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects [Not yet recruiting]

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions [Completed]

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole [Completed]

Fetal and Infant Effects of Maternal Buprenorphine Treatment [Recruiting]

Observational Study of Misuse of High Dose Buprenorphine (Subutex� or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) [Completed]

Study of Probuphine in Patients With Opioid Dependence [Terminated]

Re-Treatment Study of Probuphine in Opioid Addiction [Completed]

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Recruiting]

Improved Strategies for Outpatient Opioid Detoxification [Recruiting]

Cocaine Use Reduction With Buprenorphine [Completed]

Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients [Completed]

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain [Withdrawn]

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain [Completed]

Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine [Completed]

Drug Interaction & Methadone & Buprenorphine [Completed]

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain [Terminated]

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir) [Completed]

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients [Recruiting]

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches [Recruiting]

HIV Risk Reduction in Subutex Injectors in Tbilisi [Active, not recruiting]

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) [Completed]

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") [Completed]

Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly [Completed]

The Effects of Buprenorphine on Responses to Verbal Tasks [Recruiting]

Pilot Test of a Community-based Buprenorphine Treatment Intervention [Completed]

A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence [Terminated]

Buprenorphine for Late-Life Treatment Resistant Depression [Completed]

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (Mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers [Completed]

Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine [Recruiting]

Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) [Completed]

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Completed]

Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery [Recruiting]

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [Recruiting]

Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain [Recruiting]

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. [Terminated]

Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance [Recruiting]

Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 [Terminated]

A Study of Breastfeeding in Buprenorphine Maintained Women [Enrolling by invitation]

Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals [Completed]

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine [Completed]

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence [Completed]

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. [Terminated]

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain [Terminated]

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study [Completed]

Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance [Completed]

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone [Completed]

Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children [Recruiting]

Efficacy and Safety Study of BEMA Buprenorphine in Subjects With Low Back Pain [Completed]

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) [Completed]

Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine [Completed]

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence [Completed]

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone [Completed]

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity [Completed]

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers [Completed]

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. [Completed]

Prison Buprenorphine [Completed]

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee [Completed]

Efficacy of Buprenorphine for Treatment of Acute Pain [Completed]

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders [Active, not recruiting]

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Withdrawn]

Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine [Completed]

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir [Completed]

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone [Recruiting]

Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase [Terminated]

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population [Active, not recruiting]

A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine Subdermal Implants [Active, not recruiting]

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants [Completed]

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults [Completed]

Safety and Tolerability of Buprenorphine/Naloxone Film Strips [Completed]

Examination of Cognitive Function in Patients Treated With Subutex [Completed]

Buprenorphine as a Treatment in Opiate Dependent Pain Patients [Terminated]

Sublingual Buprenorphine for Chronic Pain [Not yet recruiting]

Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO) [Recruiting]

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017